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The first committed step of sterol biosynthesis is the cyclisation of 2,3-oxidosqualene to
form either lanosterol (LA) or cycloartenol (CA). This is catalyzed by an oxidosqualene
cyclase (OSC). LA and CA are subsequently converted into various sterols by a
series of enzyme reactions. The specificity of the OSC therefore determines the final
composition of the end sterols of an organism. Despite the functional importance of
OSCs, the determinants of their specificity are not well understood. In sterol-synthesizing
oomycetes, recent bioinformatics, and metabolite analysis suggest that LA is produced.
However, this catalytic activity has never been experimentally demonstrated. Here,
we show that the OSC of the oomycete Saprolegnia parasitica, a severe pathogen
of salmonid fish, has an uncommon sequence in a conserved motif important for
specificity. We present phylogenetic analysis revealing that this sequence is common
to sterol-synthesizing oomycetes, as well as some plants, and hypothesize as to the
evolutionary origin of some microbial sequences. We also demonstrate for the first time
that a recombinant form of the OSC from S. parasitica produces LA exclusively. Our data
pave the way for a detailed structural characterization of the protein and the possible
development of specific inhibitors of oomycete OSCs for disease control in aquaculture.
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INTRODUCTION
The sterols are a diverse group of organic compounds with indispensable structural and
biochemical roles in multicellular organisms (Summons et al., 2006; Desmond and Gribaldo,
2009). The first committed step of sterol biosynthesis is the cyclisation of OS to either LA or CA,
depending on the organism (Summons et al., 2006; Xue et al., 2012). The product of this decisive
biochemical step, catalyzed by an OSC, is subjected to multiple subsequent modifications, which
ultimately determine the profile of end sterols. OSC enzymes are classed as CAS or LAS, depending
on the outcome of the reactions they catalyze, i.e., the formation of CA or LA (Figure 1). The OSC
reaction begins with the protonation of the epoxide ring of OS (Corey et al., 1997). This initiates a
ring-forming cascade which proceeds through a series of carbocation intermediates before the final
Abbreviations: CA, cycloartenol; CAS, cycloartenol synthase; LA, lanosterol; LAS, lanosterol synthase; OS, 2,3-
oxidosqualene; OSC, oxidosqualene cyclase.
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FIGURE 1 | Enzymatic cyclisation of 2,3-oxidosqualene (OS) to
lanosterol (LA) and cycloartenol (CA). Oxidosqualene cyclase enzymes
(OSC) protonate the OS substrate, leading to the production of LA or CA.
stable product forms (Woodward and Bloch, 1953; Thoma et al.,
2004). LAS and CAS reactions differ in the later mechanistic
stages of the reaction. The formation of a double bond
between C8 and C9 will lead to LA production. Conversely, a
deprotonation at C19 will cause the cyclopropyl ring to close, and
CA will form instead (Abe et al., 1993; Abe, 2007; Ohyama et al.,
2009). LA and CA are found in cellular membranes (Briolay et al.,
2009). Their biochemistry has been an area of interest for decades,
in fields ranging from human medicine to plant physiology (Dean
et al., 1967; Huff and Telford, 2005; Ohyama et al., 2009). The
primary function of LA and CA in most organisms is to serve
as intermediates in sterol synthesis, as they are precursors of the
dominant end sterols. Sterols serve a wide range of biochemical
and structural roles in diverse organisms, and are involved in
hormone production and membrane integrity among many other
examples (Summons et al., 2006).
Sterol synthesis pathways involving CA and LA have
traditionally been considered to be common to specific kingdoms
of life: CA is found in plants, while LA is found in animals
and fungi. However, it is now apparent that OSCs cannot be
categorized along such simple lines. The mechanisms underlying
the specificity of the OSC reaction within and across kingdoms
are still not fully established. For example, LAS genes have been
identified in several plants (Kolesnikova et al., 2006; Suzuki et al.,
2006; Ohyama et al., 2009) and the model dicot Arabidopsis
thaliana has functional complementary LA and CA biosynthesis
pathways, both contributing to the synthesis of a mixture of
sterols (Ohyama et al., 2009).
At the level of amino acid sequence, CAS and LAS enzymes
are highly similar, and the specific outcome of the cyclisation
reaction depends on very small differences in these enzymes.
Three specific amino acids differ between CAS and LAS enzymes.
In the human LAS, these are at positions 381, 449, and 453. Point
mutations at these positions (or their equivalents in homologous
proteins) affect the C19 deprotonation step of the reaction (Meyer
et al., 2002; Segura et al., 2002; Sawai et al., 2006; Summons et al.,
2006; and references therein). This trio of residues found in the
C-terminal domain of OSCs invariably consists of Y, H, and I in
CAS enzymes. LAS enzymes show more variability, with T or Y
in the first position, followed typically by C, Q, or H in the second
position, and V in the third position (Summons et al., 2006).
The OSC of the oomycete Saprolegnia parasitica, an opportunistic
fish pathogen responsible for the devastating salmonid disease
saprolegniasis, possesses a rare Y,N,V triad that has previously
been identified only in some plant LAS enzymes (Kolesnikova
et al., 2006; Suzuki et al., 2006).
It was originally suggested that sterol synthesis in the
oomycetes proceeded via the formation of CA (Warner and
Domnas, 1981; Warner et al., 1982, 1983), but it is increasingly
the consensus view that sterol-synthesizing oomycetes in fact
produce LA (Nes et al., 1986; Madoui et al., 2009; Jiang et al., 2013;
Warrilow et al., 2014). LA has been identified as one of the major
sterols in the mycelium of S. parasitica, where CA has not been
detected (Warrilow et al., 2014). The oomycete has two putative
OSC genes (SPRG_11783 and SPRG_17895, identified by BLAST
analysis), which are therefore predicted to encode LAS enzymes
(Jiang et al., 2013). The two genes are almost identical, except
that the N-terminal part of the predicted product of SPRG_17895
is significantly truncated (Warrilow et al., 2014). Both gene
products possess the Y,N,V triad that is believed to determine
enzyme specificity. It is, however, unclear if both proteins are
catalytically active enzymes, as there is limited information on the
other protein features required for LAS activity.
As no oomycete OSCs have been biochemically characterized
to date, we were motivated to undertake a thorough analysis
of the S. parasitica OSC to obtain a clear understanding of
OS cyclisation in this oomycete, and gain insights into the
sterol synthesis pathway. In the longer term this fundamental
knowledge may open up new avenues of inhibitor development
for disease control in aquaculture by specifically targeting the
sterol biosynthetic pathway of the fish pathogen.
MATERIALS AND METHODS
All chemicals and reagents were obtained from Sigma Aldrich (St
Louis, MO, USA) unless otherwise indicated.
Bioinformatic Analyses
The predicted LAS genes of S. parasitica were aligned against
63 predicted OSC sequences selected from various taxa
Frontiers in Microbiology | www.frontiersin.org 2 November 2016 | Volume 7 | Article 1802
fmicb-07-01802 November 7, 2016 Time: 13:36 # 3
Dahlin et al. Lanosterol Biosynthesis in an Oomycete Pathogen
(Supplementary Table S1). Potential OSCs were selected based
on published studies of enzyme characterization, the Brenda
database (Chang et al., 2015), and/or Blast analysis using the
NCBI database1. For phylogenetic analysis in diverse organisms,
we only used the catalytic domains of the sequences. The
phylogeny software PhyML (version 3.1, Guindon et al., 2010)
was used to generate a phylogenetic tree by means of the
Blosum62 model of amino acid substitution, with bootstrapping
of 100 replicates. The Molecular Evolutionary Genetics Analysis
(version 6) tool MEGA6 (Tamura et al., 2013) was used to view
and construct the phylogenetic tree. Adobe Illustrator CS5 and
Microsoft Office Power Point were used to produce the final
presentation of the tree.
RNA Extraction and cDNA Synthesis
Saprolegnia parasitica strain “Coker 1923” (CBS 223.65; GenBank
JX418013) was obtained from the Centraal Bureau voor
Schimmel Culture (CBS, Baarn, Netherlands). Cultures were
maintained on solid (2% agar) minimal medium (Machlis, 1953)
at 25◦C in the dark. For mycelium production, 5-mm plugs
were excised from cultures on agar plates and incubated in
liquid minimal medium (Machlis, 1953) without agitation for
3 days at 25◦C in the dark. The resulting mycelium was washed
three times with filter-sterilized water and frozen in liquid
nitrogen for storage at −80◦C. Total RNA was isolated from
ground S. parasitica mycelium using the RNeasy Plant Mini Kit
from Qiagen AB (Sollentuna, Sweden), used according to the
manufacturer’s instructions, including treatment with RNase-free
DNase to remove DNA contamination (Ambion TURBO DNA-
free Kit from Thermo Fisher Scientific, Stockholm, Sweden).
Template RNA for cDNA synthesis was first quantified using a
NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific),
and the quality confirmed by gel electrophoresis. The Maxima
First Strand cDNA Synthesis Kit was used to perform reverse
transcription of the total RNA (Thermo Fisher Scientific).
Cloning and Site-Directed Mutagenesis
of SPRG_11783 and SPRG_17895
Preliminary sequence analysis of the proteins encoded by
SPRG_11783 and SPRG_17895 revealed the absence of signal
peptides in both proteins (SignalP tool2, but the presence of two
potential transmembrane domains in the N-terminal region of
SPRG_11783 (ExPASy TMPred tool3).
Cloning primers for the SPRG_11783 and SPRG_17895
genes were designed using Primer 3Plus4. Primer sequences are
listed in Supplementary Table S2. The full length amplicons
of SPRG_11783 (2415 bp) and SPRG_17895 (1416 bp) were
amplified from cDNA using a Phusion high fidelity polymerase
and buffer system (Thermo Fisher Scientific). The PCR protocol
utilized consisted of the following sequence: 98◦C, 30 s; 35 cycles
of [98◦C, 10 s; 71 C, 25 s; 72◦C, 25 s]; and 72◦C, 5 min. The PCR





gel (Thermo Fisher Scientific GeneJET PCR Purification Kit)
using a GeneRuler 1 kb DNA ladder to indicate that bands were
of the correct size (Thermo Fisher Scientific). The Gateway R©
System Ready was used for cloning, with the pENTRTM/SD/D-
TOPO R© Vector as entry vector and the Gateway pET-DEST42
Vector as expression vector (both from Invitrogen, Carlsbad,
CA, USA). The Gateway R© System was used according to the
manufacturer’s instructions. The resulting expression plasmids
included a gene for ampicillin resistance and a C-terminal
hexahistidine (His6) tag for protein purification. Confirmation
of the insertion and frame of the cloned genes was achieved by
plasmid sequencing (Eurofins Genomics, Ebersberg, Germany).
Plasmids were transformed into Escherichia coli cells by heat
shock at 42 C for 30 s. OneShot E. coli Top10 cells (Thermo
Fisher Scientific) were used for plasmid amplification. For protein
production, plasmids were recovered using the Thermo Fisher
Scientific GeneJET Plasmid Miniprep kit and were transformed
into E. coli BL21 (DE3) cells (New England BioLabs Inc., Ipswich,
MA, USA).
Point mutations were introduced into the SPRG_11783 gene
by site-directed mutagenesis of the plasmid containing the gene,
by a simple PCR-based method using the Pfx polymerase enzyme
and buffer system (Thermo Fisher Scientific). Primers were
used to introduce a N518H and/or a V522I mutation, altering
the Y,N,V amino acid triad to Y,H,I; Y,H,V; or Y,N,I. Primer
sequences are presented in Supplementary Table S2. The PCR
protocol utilized in each case consisted of the following steps:
94◦C, 5 min; 22 cycles of [94◦C, 30 s; 55◦C, 1 min; 68◦C, 6 min];
68◦C, 15 min. The restriction enzyme DpnI (Thermo Fisher
Scientific) was used to degrade methylated parental DNA by
adding 1 µL of the enzyme solution to 50 µL PCR reaction, and
incubating for 1 h at 37 C. PCR product was purified using a PCR
Clean-Up kit (Qiagen AB, Sollentuna, Sweden), and mutated
plasmids were transformed into OneShot E. coli Top10 cells
by heat shock. Plasmid sequences were confirmed to contain
the desired mutation(s) by sequencing (Eurofins Genomics,
Ebersberg, Germany). For protein production, constructs were
transformed into E. coli BL21 cells.
Protein Expression and Purification
One-liter cultures of BL21 DE3 E. coli cells harboring the desired
plasmid were grown at 37◦C with rotary shaking (180 rpm)
in LB medium containing ampicillin (50 µg mL−1), to an
OD600 of 0.4–0.6, when protein production was induced by
the addition of IPTG (isopropyl α-D-thiogalactopyranoside) to
a final concentration of 0.2 mM. The incubator temperature
was lowered to 20◦C, and protein production continued for
48 h. Cells were harvested by centrifugation at 5000 × g for
30 min, and were then re-suspended in 20 mL Buffer A (50 mM
sodium phosphate buffer (pH 7.4) with 20 mM imidazole). Cells
in buffer A were sonicated for 2 min to lyse cells. Proteins
were separated from cell debris by centrifugation at 17000 × g
for 30 min at 4◦C. The supernatant liquid contained the
over-expressed protein, which was His-tag purified by IMAC
(immobilized metal ion affinity chromatography). Econo-Pac
Chromatography Columns (Bio-Rad, Hercules, CA, USA) were
used and loaded with 5 mL IMAC SepharoseTM 6 Fast Flow
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resin (GE Healthcare, Uppsala, Sweden), charged with NiCl2 and
pre-conditioned with Buffer A. Proteins were loaded onto the
column and washed with four volumes of Buffer A to remove
loosely bound non-specific proteins. His-tagged proteins were
eluted using a step-wise gradient of 0–100% Buffer B (50 mM
sodium phosphate buffer (pH 7.4) with 500 mM imidazole).
Eluted proteins were concentrated and washed into 50 mM
sodium phosphate pH 7.4 using a 30-kDa cut-off Amicon Ultra
centrifugal filters (Merck Millipore, Cork, Ireland). Protein purity
and approximate size were confirmed by SDS-PAGE, using
a PageRuler Plus pre-stained protein ladder (Thermo Fisher
Scientific). The concentration of purified SPRG_11783 protein
was determined using the Bradford assay (Bradford, 1976).
A band corresponding to the over-expressed protein was excised
from an SDS-PAGE gel and subjected to in-gel trypsin proteolysis
and LC-MS/MS analysis following the protocol described in
Srivastava et al. (2013).
ENZYME ACTIVITY ASSAYS
In vivo Assay
Ten milliliter cultures of BL21 E. coli cells transformed with
plasmid DNA containing the gene of interest were grown at
37◦C with rotary shaking (180 rpm) in LB medium containing
ampicillin (50 µg mL−1) and additionally supplemented with
5 µL of a 5 nM stock OS (Sigma-Aldrich Sweden AB, Stockholm,
Sweden, product number 41043), for a total amount of 10.7 µg
OS added to the cultures. The OS was first solubilized in
methanol, and the appropriate volume of this was pipette
directly into the culture medium, with no additional compounds.
When an OD600 of 0.4–0.6 was reached, recombinant protein
production was induced by the addition of IPTG to a final
concentration of 0.2 mM. Protein production was allowed to
proceed overnight at 37◦C. The cultures were then sonicated and
sterols were extracted as outlined below. Control experiments
were performed on non-induced cultures and induced cultures
lacking OS. Additional control experiments using cells expressing
green fluorescent protein instead of SPRG_11783 were also
performed.
In vitro Assay
2,3-Oxidosqualene (10.7 µg) was mixed with increasing amounts
of the recombinant SpLASA protein (37.5, 75, or 112.5 µg)
purified as described above. The OS was first solubilized in
methanol, and the appropriate volume of this was pipette directly
into the reaction mixture, with no additional compounds. The
assay was performed in 50 mM sodium phosphate buffer (pH 7.4)
with a final volume of 1.5 mL and an incubation time of 24 h at
25◦C. Cholesterol was used as an internal standard and added to
the reaction mixtures prior to sterol extraction and analysis.
Extraction and GC-MS Analysis of
Sterols
A mixture of chloroform:methanol (1:2; 3.75 volumes) was added
to each in vitro reaction mixture. After 1 h incubation at room
temperature under continuous agitation the chloroform phase
was recovered by centrifugation at 2000 × g and 17◦C for
10 min. The solvent was evaporated under nitrogen gas and
the dried sterols were silylated at 60◦C for 1 h in the presence
of a commercial mixture of BSTFA [N,O-bis(trimethylsilyl)
trifluoroacetamide] and TMCS (trimethylchlorosilane) (99:1;
Supelco, Sigma-Aldrich Sweden AB, Stockholm, Sweden) diluted
in pyridine (1/1 v/v). The modified sterols were then dried under
nitrogen gas and dissolved in hexane. Analysis of the sterol
derivatives was performed by gas chromatography coupled to
mass spectrometry [Hewlett-Packard, model 6890 (GC) and 5973
(MS)] using a CP-Sil 5 CB column (30 m × 0.25 mm; Agilent
Technologies). Helium was used as a carrier gas (1 mL min−1).
The temperature of the GC oven was initially set at 245◦C,
and successively increased to 265◦C at a rate of 3.5◦C min−1
and 310◦C at a rate of 0.5◦C min−1. MS spectra were recorded
between 40 and 800 m/z. The identity of the detected sterols
was confirmed by comparison to the GC retention times and
MS fragmentation patterns of commercial standards run in this
experiment and available in the literature. The peak area of the
internal standard (cholesterol) was used to quantify the sterols
present in the samples as well as OS.
RESULTS AND DISCUSSION
Oxidosqualene Cyclases in S. parasitica
To date, support for a reconstructed sterol synthesis pathway
in S. parasitica has derived from bioinformatics and analysis of
sterol profiles, showing that LA is abundant in the mycelium
while CA is not detectable (Jiang et al., 2013; Warrilow et al.,
2014). The putative OSC enzymes encoded by the genes
SPRG_11783 and SPRG_17895 are proposed to perform the
cyclisation of OS to LA, the first committed step of sterol
biosynthesis in S. parasitica (Jiang et al., 2013). However,
no functional characterization of these or any orthologous
oomycete genes have yet been presented. SPRG_17895 encodes
a 472 amino acid protein, which is a truncated duplicate of
SPRG_11783, beginning at residue 334 of the full-length 805
amino acid sequence (Warrilow et al., 2014). The proteins
encoded by SPRG_11783 and SPRG_17895 are hereafter referred
to as SpLASA and SpLASB, respectively. Although SpLASB is
a significantly shorter protein, over the region shared by both
proteins they show 99% identity. There are just three amino acid
differences: compared to SpLASA, SpLASB has M470I, N492S,
and A692V (positions numbered for SpLASA). The predicted
catalytic domain of SpLASA contains two separate Pfam
squalene-hopene cyclase domains (PF13249 at the N-terminal
and PF13243 at the C-terminal) (Finn et al., 2016) (Figure 2A).
SpLASB contains solely the C-terminal domain, so it is unclear
whether this protein is catalytically active. Further sequence
analysis of SpLASA indicates the presence of two potential
transmembrane domains at the N-terminal end of the protein
(amino acids 19–39 and 164–183), which are not found in
SpLASB. Due to the very high level of sequence similarity
between the two genes, it is difficult to determine whether both
are expressed by S. parasitica. Our own preliminary analyses
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FIGURE 2 | Predicted domains of the two OSC enzymes from S. parasitica (SpLASA and SpLASB) and sequence alignment with similar enzymes
from different taxa. (A) SpLASA (SPRG_11783) contains two separate Pfam squalene-hopene cyclase domains. SpLASB (SPRG_17895) contains the C-terminal
domain only. (B) Protein sequence alignment of diverse OSC enzymes highlighting a key amino acid triad involved in enzyme. The numbers given for the positions of
the three amino acids are from the human OSC. Variations in these positions are highlighted with different colors and the enzymes are grouped into LAS and CAS.
The S. parasitica sequence shown is from SpLASA. Arabidopsis thaliana CA and A. thaliana LA refer to the CAS and LAS enzymes from A. thaliana, respectively.
(qPCR experiments, data not shown) indicate that SPRG_11783
is expressed in S. parasitica mycelium. Additionally, evidence was
presented with the sequencing of the S. parasitica genome that the
SPRG_17895 gene is expressed, and is more highly expressed in
cysts than in the mycelium (Jiang et al., 2013).
Sequence alignment of SpLASA and SpLASB with other
known and predicted OSCs showed that both oomycete proteins
contain an unusual Y,N,V pattern at amino acid positions 450,
518, and 522 for SpLASA, and 117, 185, and 199 for SpLASB
(Figure 2B). Previous experiments have demonstrated that these
positions are crucial in distinguishing LAS and CAS enzymes
(Summons et al., 2006), although the precise role of these amino
acids in activity, substrate binding, or other mechanistic action, is
unknown. This triad of amino acids is more variable in LAS than
CAS enzymes, where it appears to always be Y,H,I (Figure 2B).
The Y,N,V pattern of the S. parasitica proteins has previously
only been observed in plant enzymes, characterized as LAS in
A. thaliana and Lotus japonicus (Kolesnikova et al., 2006; Suzuki
et al., 2006) (Figure 2B).
Phylogenetic Analysis of OSC Enzymes
We performed a phylogenetic analysis of LAS and CAS enzymes
using 63 characterized or predicted OSC protein sequences
from different taxonomic groups of organisms (Supplementary
Table S1). A phylogenetic tree was produced using only
the predicted catalytic domains of the selected sequences to
exclude interference from non-catalytic domains. The tree allows
comparison of the occurrence of different amino acid motifs,
enzyme specificities, and sterol profiles. This analysis is unlikely
to be sufficient to infer a complete evolutionary history of OSC
genes. Nevertheless, four distinct clades are apparent (Figure 3).
Group 1 contains only sequences from the Euglenozoa phylum.
Group 2 contains sequences from the Heterokonta phylum,
including the oomycete class, as well as three bacterial sequences.
Group 3 includes sequences from animals, fungi, amoeba, and
one bacterium. Group 4 contains enzymes from plants and
red algae. The bacteria are the only taxonomic group not all
found in the same clade: they are found in Groups 2 and 3.
All predicted CAS enzymes have the Y,H,V motif, whereas there
are five different amino acid patterns in predicted LAS enzymes
([T,C,V]; [T,Q,V]; [Y,Q,V]; [Y,H,V]; [Y,N,V]). Groups 2–4 all
contain examples of both CAS and LAS sequences. Some plant
species have both LAS and CAS genes, but so far it has been
conclusively demonstrated only for A. thaliana that both are
functional (Ohyama et al., 2009).
Sequences from the Euglenozoa (Group 1) are distinct from
all other OSC enzymes, and possess a unique Y,Q,V amino acid
pattern. Examples from Trypanosoma brucei and Trypanosoma
cruzi have been biochemically characterized as LAS, and therefore
we hypothesize that the others in the group share the same
activity (Buckner et al., 2000; Joubert et al., 2001).
The next branching point clearly separates the heterokonts,
including the oomycetes, from the other clades. Group 2
contains both CAS and LAS enzymes. The CAS enzymes from
the algae Ectocarpus siliculosus, Thalassiosira pseudonana, and
Phaeodactylum tricornutum [experimentally shown to increase
Frontiers in Microbiology | www.frontiersin.org 5 November 2016 | Volume 7 | Article 1802
fmicb-07-01802 November 7, 2016 Time: 13:36 # 6
Dahlin et al. Lanosterol Biosynthesis in an Oomycete Pathogen
FIGURE 3 | Phylogenetic analysis of 63 characterized and predicted OSC sequences. Species group into four clades, numbered 1–4. The outer colored ring
denotes the taxonomic groups of the species from which the sequences originate, as indicated by the color key. The small colored hexagons each correspond to a
different triad amino acid pattern. The names of the species for which enzyme specificity has been biochemically demonstrated are underlined. Bootstrap values
from 100 replicate analyses are shown at each root branch. Full organism names and sequence identification numbers are listed in Supplementary Table S1.
CA accumulation in transformed yeast (Fabris et al., 2014)] have
the classical Y,H,I motif, while the oomycete LAS enzymes all
have the Y,N,V motif seen in SpLASA and SpLASB. We identified
predicted LAS sequences from the oomycetes Saprolegnia
diclina, Aphanomyces euteiches, Aphanomyces invadans, and
Aphanomyces astaci (Figure 3). The same Y,N,V motif is also
present in some plant enzymes (Group 4, see below). A sub-
group containing three bacterial OSC sequences also clusters in
Group 2 (Stigmatella aurantiaca, Methylococcus capsulatus and
Gemmata obscuriglobus). These display both CAS and LAS amino
acid patterns, including the LAS Y,H,V triad, which appears to be
unique to bacteria. Y,H,V bacterial sequences have been proposed
as representing an early ancestral OSC gene, suggesting that the
earliest sterol synthesis pathways originated in prokaryotes and
proceeded via LA production (Pearson et al., 2003; Lamb et al.,
2007; Nakano et al., 2007). The oomycete sequences may derive
from this early ancestor, after a single amino acid change to
Y,N,V. One could perhaps speculate that the algal sequences may
derive from an early Y,H,I bacterial ancestor (e.g., S. aurantiaca),
but more investigation is needed to be sure of this.
Group 3 sequences are all predicted LAS enzymes, with the
exception of a sub-group of amoebal enzymes and the sole
bacterial sequence in the group (Fluviicola taffensis). The amoebal
and bacterial sequences possess the Y,H,I motif and are predicted
to be CAS. This motif differs significantly from the T,Q,V and
T,C,V triads dominating the clade, with three separate changes
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FIGURE 4 | SDS-PAGE analysis and identity confirmation of the recombinant SpLASA protein. (A) The recombinant protein expressed in E. coli was purified
by immobilized metal ion affinity chromatography (IMAC). (B) The identity of the Coomassie blue-stained SDS-PAGE band was confirmed by mass spectrometry
analysis after in-gel partial proteolysis with trypsin. The peptides identified unequivocally confirmed that the purified recombinant protein corresponds to SpLASA.
The corresponding spectra are presented in Supplementary Figure S2.
in the amino acid patterns, implying multiple mutational events
between sequences otherwise similar enough to co-cluster in this
analysis. Some bacterial OSC genes may have been obtained via
horizontal transfer event(s) from other organisms (Desmond and
Gribaldo, 2009), perhaps explaining the existence of an OSC in
F. traffensis so dissimilar to the bacterial sequences in Group 2
(Figure 3).
Group 4 mostly comprises CAS enzymes, with the exception
of a sub-group of unusual plant LAS enzymes, which have a
Y,N,V motif, a two amino acid difference from the CAS Y,H,I
motif in the rest of the clade. As the Group 4 LAS sequences
have the same triad as the oomycete enzymes, it is tempting
to suggest some cross-species transfer of genetic information
leading to this dual appearance of the motif in such distinct
clades. However, although the monocot (Zea mays and Triticum
urartu) and dicot (L. japonicus and A. thaliana) LAS genes share
the Y,N,V amino acid pattern, they cluster quite distinctly from
each other on the tree. The dicot LAS genes therefore appear
to have emerged from an earlier ancestor than the monocot
LAS genes (Figure 3). This finding is consistent with previous
suggestions that the synthesis of sterols in dicot plants derive
from an ancestral LAS (Xue et al., 2012). To date, no monocot
LAS enzymes have been shown to support a functional LA
synthesis pathway in plants (Xue et al., 2012). The monocot
LAS sequences in our analysis grouped with plant CAS genes,
which conforms to a previously proposed theory that monocot
LAS genes derive from a duplicated CAS gene (Xue et al., 2012).
A similar gene duplication event may explain the presence of
two apparent OSC genes in the S. parasitica genome, encoding
SpLASA and SpLASB.
If the Y,H,V motif is indeed a feature of a common ancestral
bacterial LAS, from which OSCs in other species diverged
(Pearson et al., 2003; Lamb et al., 2007), we can hypothesize that
three distinct single mutations have occurred, leading separately
to the Y,Q,V (Euglenazoa LAS), Y,N,V (oomycete LAS), and
Y,H,I (CAS) sequences. Higher order eukaryotes with the T,Q,V
(fungi) or T,C,V (animals) motif in their OSC enzymes have
undergone two changes from the ancestral sequence. The Y381T
(position numbered for the human LAS) change may have arisen
in an ancestor common to animals and fungi. The animal and
fungal proteins then separately underwent an additional change
from T,H,V, leading to different sequences with the same LAS
specificity.
Functional Characterization of SpLASA
SpLAS Cloning, Expression, and Purification
The genes encoding SpLASA and SpLASB were amplified
from cDNA by PCR. They were then cloned into the pET-
DEST42 Vector which contains a C-terminal His6 tag for affinity
purification of recombinant proteins. Site-directed mutagenesis
of SpLASA was used to produce changes in the Y,N,V amino
acid triad at positions 450, 518, and 522, to make [Y,H,V];
[Y,N,I]; and [Y,H,I]. Following sequence confirmation, plasmids
of SpLASA, SpLASB, and the mutant variants of SpLASA, were
transformed into Escherichia coli strain BL21 (DE3) for over-
expression. Production and purification of soluble protein was
successful in the case of SpLASA. This protein was purified
by two rounds of IMAC, and its successful enrichment was
demonstrated by SDS-PAGE analysis (Figure 4A), which also
confirmed the purified protein has the predicted molecular
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FIGURE 5 | GC-MS analysis of the product formed by E. coli cells expressing SpLASA and grown in the presence of the OS substrate. (A) Control
E. coli BL21 cells producing green fluorescent protein showed no conversion of the OS substrate. (B) E. coli cells that expressed SpLASA but that were not induced
by IPTG for protein expression showed no conversion of OS. (C) E. coli cells that expressed SpLASA and were induced by IPTG for protein expression specifically
converted a portion of the OS substrate to LA. (D) Negative control performed on E. coli cells producing SpLASA and grown in the absence of the OS substrate
shows no conversion of OS. The major peak detected in all samples is an unidentified compound that does not correspond to any sterol as judged by MS analysis
(not shown). The identity of the OS and LA GC peaks were assigned by comparison to standards and confirmed by inspection of their MS fragmentation patterns.
weight of ∼91 kDa. Additional silver staining of a gel revealed
the presence of some faint protein bands, likely arising from
the bacterial expression strain (Supplementary Figure S1):
several control experiments were performed to ensure that no
OSC activity could be linked to these bacterial proteins (see
below). Identification of the purified recombinant protein was
additionally confirmed by mass spectrometric analysis of peptides
generated by trypsin hydrolysis of an excised gel band (Figure 4B;
Supplementary Figure S2). SpLASA expression yields were low,
with typically around 50–100 µg purified protein recoverable
from one liter bacterial culture. This is in accordance with
previous reports describing the difficulty of OSC production
in bacterial expression strains (Corey et al., 1997), and may
be due to the predicted transmembrane regions of SpLASA,
which rendered the protein unstable in the intracellular bacterial
environment. However, SpLASA yields in our experiments were
consistent and reproducible, and bacterial cultivation could be
scaled up to produce sufficient protein for enzymatic assays.
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FIGURE 6 | GC-MS analysis of the product formed in vitro by the purified recombinant SpLASA protein expressed in E. coli. (A,B) Gas chromatogram
and corresponding MS fragmentation pattern of OS and LA standards, respectively. (C) GC-MS analysis of the reaction mixture recovered after incubation of
112.5 µg of the purified recombinant SpLASA protein with 10.3 µg OS showing conversion of OS to LA. (D) Incubation of increasing amounts of the purified
recombinant SpLASA with a constant amount of OS (10.3 µg). The amount of LA formed increased linearly in the presence of increasing amounts of SpLASA.
Reciprocally, the amount of OS recovered at the end of the reaction decreased linearly.
Despite repeated attempts and large volumes of culture, no
over-expression of SpLASB, or any mutant variant of SpLASA
could be achieved. No bands were visible on SDS-PAGE by
Coomassie stains, but protein samples were still subjected to
trypsin proteolysis and MS analysis to screen for low levels
of these recombinant proteins: no peptides corresponding to
S. parasitica proteins were detected in any case. Cultures of cells
transformed with these plasmid also showed no activity in the
in vivo assay (see below).
In vivo Conversion of OS
Escherichia coli BL21 cells harboring the SPRG_11783 gene in
cultures supplemented with OS were assessed for their ability
to cyclize the molecule into a sterol. Control experiments were
performed using cells transformed with a plasmid with a non-
OSC gene (green fluorescent protein, GFP). Following IPTG
induction for protein expression, and incubation for a further
16 h, E. coli cells were sonicated in the growth medium, followed
by chloroform-methanol extraction of sterols. Analysis by GC-
MS confirmed the presence of LA in the cultures producing
SpLASA (Figure 5). Furthermore, LA was not detected in the
control bacterial cultures carrying the GFP gene, or in SpLASA
cultures which were not induced, or in induced SpLASA cultures
not supplemented with OS (Figure 5). These data confirm
unequivocally that SpLASA has LAS activity, conferring upon
the host bacterial cells the ability to convert OS into LA. No
other sterols were detected in the SpLASA samples, showing
that LA is the only catalytic reaction product under these
conditions. The stability of OS in LB medium was assessed
by incubating 10.7 µg of the substrate in 1.5 mL medium
overnight at room temperature. GC-MS analysis showed that
there was no spontaneous conversion of the substrate into LA
(Supplementary Figure S3). We hypothesize that the conversion
of OS into LA by the cells over-expressing SpLASA occurred
after uptake of the substrate into the cells. A detectable amount
of conversion only took place when the OS was included in
culture media from the beginning of bacterial growth. Adding
the OS after the induction of protein expression did not lead
to conversion to LA. Likewise, adding the OS to sonicated cells
and incubating for a 24 h period resulted in no conversion
to LA.
In vitro Conversion of OS by SpLASA
Purified recombinant SpLASA was tested for its ability to cyclize
OS by incubating 10.7 µg of OS with 37.5, 75, or 112.5 µg of the
protein for 24 h at 25◦C. Sterols were extracted from the reaction
mixtures, silylated, and analyzed by GC-MS (Figure 6). These
experiments confirmed the specific conversion of OS into LA. No
other cyclized products were identified, whereas traces of several
reaction products have been detectable in assays of OSC enzymes
from A. thaliana and other organisms (Phillips et al., 2006).
Quantification of substrate and product by GC-MS analysis
after enzymatic reactions showed that the proportion of LA
increased linearly with increasing protein concentration, while
the OS concentration decreased proportionally (Figure 6D). This
dose-dependency of the reaction confirms that the cyclisation
is enzymatically catalyzed, as increasing protein concentration
led to an increased conversion of substrate into product.
Additionally, our preliminary stability tests showed that there
is no spontaneous cyclisation of the substrate in water or the
reaction buffer (Supplementary Figure S3). The total amount of
material recovered by chloroform-methanol extraction remained
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relatively constant in all samples (Supplementary Figure S4),
supporting the accuracy of these quantification values.
Implications for Oomycete Sterol Synthesis
The inhibition of sterol synthesis in the oomycetes is a promising
avenue for targeted applications in the fight against the spread of
these pathogenic microorganisms. The drug clotrimazole, which
inhibits a CYP51 enzyme involved in sterol synthesis, has been
shown to be effective at controlling the growth of S. parasitica
(Warrilow et al., 2014), and other steps in the biosynthetic
pathway are potential targets for similar disruption. SpLASA is
the first biochemically characterized oomycete OSC and may
represent a drug target for sterol synthesis inhibition. Indeed,
the use of OSC inhibitors as anti-microbial agents has been
successfully explored for some human pathogens (Buckner et al.,
2001; Hinshaw et al., 2003). However, CYP51 inhibitors tend
to be broadly acting, and may affect not only the oomycete
pathogen but also animals and plants in the surrounding local
environment. Conversely, a highly targeted inhibition of OSCs
with the Y,N,V amino acid triad would enable precise disruption
of sterol synthesis in oomycete pathogens. Design and application
of a drug with such a high level of specificity will require
much more detailed knowledge of the structure and mechanism
of oomycete LAS enzymes. With structural and mechanistic
information available it may become possible to develop new
molecules that mimic transition state or intermediate compounds
formed from OS during the cyclisation reaction (Buckner
et al., 2001; Hinshaw et al., 2003). Targeted disruption of the
SPRG_11783 gene would be necessary to confirm that SpLASA
is the only functional LAS in S. parasitica. It may be that the
truncated protein SpLASB, or another unidentified protein, can
provide an alternative mode of sterol synthesis or acquisition.
This would compensate for the loss of active SpLASB. Such
investigations may become possible in the near future, provided
that an efficient method for gene silencing can be successfully
applied to S. parasitica. The CRISPR/Cas9 approach recently used
to disrupt an effector gene in the oomycete Phytophthora sojae
(Fang and Tyler, 2016) holds promise for silencing genes in other
oomycetes such as S. parasitica and perform in vivo functional
characterization.
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